1.Exploration on YANG Jun's thoughts on clinical practice of acupuncture and moxibustion.
Ming ZHANG ; Zhibo ZHANG ; Qingping ZHANG ; Jun YANG ; Chenhui GAO ; Lan MEI ; Jinjin ZHENG
Chinese Acupuncture & Moxibustion 2025;45(11):1627-1632
The paper summarizes Professor YANG Jun's thoughts on clinical treatment with acupuncture and moxibustion. Professor YANG Jun puts forward the "refined mode for diagnosis and treatment of diseases with acupuncture and moxibustion", aiming to improve the capacity of diagnosis and treatment in clinical practice. He advocates that the diagnosis and treatment should be guided by the identification of etiologies, syndromes and meridians; in accordance with regulating the shape/form, balancing yin and yang, and harmonizing the mind; and by means of skillful techniques of acupuncture and moxibustion, simplified selection of acupoints and delicate manipulations. Besides, he stresses on the combination of multiple techniques of acupuncture (such as penetrating technique with long needle, stuck needling by lifting and pulling, and micro-acupuncture systems) with moxibustion techniques (moxibustion for resolving stasis and unblocking collaterals, pressing moxibustion, borneol moxibustion, moxibustion with medicinal plaster) in clinical practice, so as to enhance the therapeutic effects.
Moxibustion/methods*
;
Acupuncture Therapy/methods*
;
Humans
;
China
;
Acupuncture Points
2.Analysis of effect and safety of vibrating mesh atomization inhalation of PS combined with NCPAP on neonatal respiratory distress syndrome
Zhibo GAO ; Ye LI ; Yushen LIU
Clinical Medicine of China 2025;41(5):321-328
Objective:To analyze the effect and safety of vibrating mesh atomization inhalation of pulmonary surfactant (PS) combined with nasal continuous positive airway pressure (NCPAP) in the treatment of neonatal respiratory distress syndrome (NRDS).Methods:150 Children with NRDS in department of pediatrics of the Second Affiliated Hospital of Air Force Medical University from May 2021 to May 2024 were enrolled as study subjects for a prospective cohort study. According to the propensity score matching, children who adopted traditional intratracheal infusion of PS combined with NCPAP were selected as infusion group (75 cases), and children who received vibrating mesh atomization inhalation of PS combined with NCPAP treatment were included in atomization group (75 cases). The therapeutic effect, breathing conditions, blood gas changes [pH value, arterial partial pressure of oxygen (PaO 2), arterial partial pressure of carbon dioxide (PaCO 2)] and NCPAP parameters changes [fraction of inspired oxygen (FiO 2), oxygenation index (OI), positive end-expiratory pressure (PEEP)] before and after treatment and incidence rates of adverse reactions were compared between groups. Normally distributed quantitative data were expressed as xˉ± s, and t test was used for inter-group comparison. Counting data were expressed as case(%), and χ2 test was used for inter-group comparison. Comparison of repeated measurement indicators at different time points using repeated meausurement analysis of variance. Results:There was no statistical significance in the total effective rate of treatment between groups ( P>0.05). The NCPAP treatment time and oxygen therapy time were (4.69±0.61) d and (14.52±1.16) d in atomization group, significantly shorter than (5.08±0.80) d and (15.30±1.28) d in infusion group ( t=3.36, 3.91, P=0.001, <0.001). The success rate of one-time weaning in atomization group was 88.00% (66/75), significantly higher than 73.33% (55/75) in infusion group ( χ2=5.17, P=0.023). After 3 and 7 days of treatment, the pH [(3 d : 7.31±0.04, 7 d: 7.34±0.03) and (3 d: 7.35±0.03, 7 d: 7.38±0.02)], PaO 2 [(3 d: (58.55±6.51) mmHg (1 mmHg=0.133 kPa), 7 d: (68.19±7.58) mmHg ) and (3 d: (65.16±7.24) mmHg, 7 d: (75.57±8.40) mmHg)] in infusion group and atomization group increased obviously over time, and the pH and PaO 2 were significantly higher in atomization group than those in infusion group ( t=6.93, 8.68, 5.88, 5.65, all P<0.001). The PaCO 2 in infusion group and atomization group (3 d: (48.45±5.38 ) mmHg, 7 d: (43.64±4.85 ) mmHg) and (3 d: (45.41±5.02) mmHg, 7 d: (40.35±4.59) mmHg) decreased obviously over time at 3 and 7 days of treatment, and the PaCO 2 in atomization group was significantly lower than that in infusion group ( t=3.58, 4.27, both P<0.001). After 3 days of treatment, FiO 2 [(41.06±4.67)% and (38.52±4.21)%] and PEEP [(4.39±0.19) cmH 2O (1 cmH 2O=0.098 kPa) and (4.28±0.13) cmH 2O] in infusion group and atomization group decreased obviously, and the indicators in atomization group were significantly lower than those in infusion group ( t=3.50, 4.14, both P<0.001). After 3 days of treatment, oxygenation index (OI) in infusion group and atomization group [(278.35±30.48) mmHg and (296.67±32.96) mmHg] increased obviously, and the OI in atomization group was significantly higher than that in infusion group ( t=3.53, P<0.001). The incidence of adverse reactions in atomization group was 4.00% (3/75), significantly lower than 13.34% (10/75) in infusion group ( χ2=4.13, P=0.042). Conclusion:Both vibrating mesh atomization inhalation of PS or traditional infusion of PS combined with NCPAP have similar efficacy in the treatment of NRDS, but vibrating mesh atomization inhalation of PS combined with NCPAP can more effectively improve the breathing conditions, blood gas indicators and NCPAP parameters of children, and has higher safety.
3.Protective mechanism of Dachengqi decoction on intestinal mucosal barrier:a network pharmacology study focused on autophagy
Xing LU ; Kai ZHANG ; Jing ZHAO ; Shiya ZHANG ; Zhibo LI ; Xinjing GAO ; Lei XU ; Chengfen YIN
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2025;32(4):454-459
Objective To explore and verify the active components of Dachengqi decoction in regulating autophagy and its mechanism of protecting the intestinal mucosal barrier through network pharmacology and animal experiments.Methods The chemical components and autophagy-related target points of Dachengqi decoction were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database Analysis Platform(TCMSP)and GeneCards databases.The intersection of the drug target points and disease target points was taken and analyzed.The Cytoscape 3.10.2 software's Network Analyzer tool was used to analyze the drug components and target points,and the core target points were screened out to construct a traditional Chinese medicine compound regulatory network.The drug active component target point-disease network model and protein-protein interaction(PPI)network were visualized.Then,30 C57BL/6J mice were randomly divided into the Dachengqi decoction group,the intestinal infection group,and the control group,with 10 mice in each group.The intestinal infection group was given 200 μL/d of Klebsiella pneumoniae strain by gavage for 5 consecutive days,with a colony count of 109 CFU/mL,to create an intestinal infection model.The control group was given 200 μL/d of sterile normal saline by gavage.The Dachengqi decoction group(drug composition:Rhubarb 12 g,Aurantii Fructus 12 g,Magnolia Officinalis 24 g,Mirabilite 9 g,the drugs were dissolved in boiling distilled water to make a 1 kg/L solution)was given by gavage at a dose of 8 g·kg-1·d-1 for 3 consecutive days,and then given Klebsiella pneumoniae by gavage for 5 consecutive days on the 4th day.Detection indicators and methods:after the experiment,the mice were sacrificed and the terminal ileum tissues were collected.The tissues were stained with hematoxylin-eosin(HE),and the pathological changes of the intestinal mucosa were observed under a light microscope;immunofluorescence staining was used to observe the positive expressions of junction proteins ZO-1,Claudin-2,light chain 3-Ⅱ(LC3-Ⅱ),and Beclin-1 and the intestinal mucosal autophagy;the mRNA expression levels of autophagy genes were determined by polymerase chain reaction(PCR).Results The intersection of the obtained drug targets and disease targets yielded 111 potential autophagy-related targets for drug treatment of diseases.Key targets included β2-adrenergic receptor(ADRB2),heme oxygenase-1(HO-1),etc.,and the signaling pathways involved included AMP-activated protein kinase(AMPK)pathway,mammalian target of rapamycin(mTOR)pathway,etc.Animal experiments confirmed that the intestinal mucosal barrier function in the Dachengqi decoction group was better than that in the intestinal infection group,and the positive expression of microtubule-associated protein 1 lingt chain 3-Ⅱ(LC3-Ⅱ)and autophagy gene Beclin1 was significantly higher than that in the intestinal infection group.Transcriptome sequencing results showed that the key genes associated with autophagy and oxidative stress included ADRB2,HO-1,etc.The mRNA expression levels of ADRB2 and HO-1 in the Dachengqi decoction group were significantly higher than those in the intestinal infection group[HO-1 mRNA expression(FPKM):11.20±0.80 vs.6.63±0.53,ADRB2 mRNA expression(FPKM):6.98±0.54 vs.3.98±0.32,both P<0.01],verifying some of the predictions from network pharmacology.Conclusions Dachengqi decoction regulates autophagy through multiple components,multiple targets and multiple pathways,protecting the intestinal mucosal barrier function and reducing the translocation of intestinal microbiota.This lays a certain foundation for further in-depth research on the mechanism of reducing intestinal bacterial translocation by Dachengqi decoction.
4.Scoparone inhibits proliferation and invasion of colon cancer cell line HCT116
Wei HAN ; Wei PAN ; Man ZHANG ; Xiangyu GAO ; Xinkai KANG ; Zhibo ZHU ; Ruiting LIU
Basic & Clinical Medicine 2025;45(11):1429-1437
Objective To investigate the effects of scoparone(Sco)on proliferation and invasion of colon cancer cell line HCT116,and its effect on the expression of epidermal growth factor receptor(EGFR).Methods 1)HCT116 cells were divided into control group,50Sco group,100Sco group and 200Sco group.The cells in con-trol group were incubated with culture medium for 48 hrs.The 50Sco group,100Sco group and 200Sco group were incubated with 50,100 and 200 μmol/L scoparone for 48 hrs respectively.2)HCT116 cells were divided into con-trol group,NC-200Sco group,NC-LV+200Sco group and EGFR-LV+200Sco group.The control group was incuba-ted with normal culture medium for 48 hrs.NC-200Sco group was incubated with 200 μmol/L scoparone for 48 hrs.NC-LV and EGFR-LV were infected into HCT116 cells in NC-LV+200Sco group and EGFR-LV+200Sco group,then incubated with 200 μmol/L scoparone for 48 hrs.Cell proliferation was detected by MTT assay and EdU stai-ning,cell apoptosis was detected by flow cytometry and cell invasion was detected by Transwell assay.EGFR mRNA was detected by RT-qPCR,the level of EGFR,Bcl-2,Bax,matrix metalloproteinase(MMP)-2 and MMP-9 protein was detected by Western blot.Results Compared to the control group,the cell viability,proportion of EdU positive cells and counting number of invasive cells in 50Sco group,100Sco group and 200Sco group all decreased(P<0.05).Cell apoptosis rate and Bax protein expression increased(P<0.05),the protein expression of Bcl-2,MMP-2 and MMP-9 decreased(P<0.05).mRNA and protein expression of EGFR were de-creased(P<0.05).Compared with NC-200 Sco group and NC-LV+200Sco group,the expression level of mRNA and protein of EGFR in EGFR-LV+200Sco group was increased(P<0.05).Cell viability,proportion of EdU posi-tive cells and counting number of invasive cells all increased(P<0.05).The cell apoptosis rate and Bax protein expression level were decreased(P<0.05).The protein expression of Bcl-2,MMP-2 and MMP-9 was increased(P<0.05).Conclusions Scoparone has anti-colon cancer cell activity and inhibits proliferation as well as invasion of colon cancer cells through inhibition of EGFR.
5.Application Progress and Classification Analysis of Rat Vascular Remodeling Models
Chaoqi GAO ; Zhibo ZHU ; Xiandong SUN
Laboratory Animal and Comparative Medicine 2025;45(5):542-550
Cardiovascular diseases(CVD)are characterized by high morbidity,disability,and mortality rates,making them one of the leading causes of human death worldwide.Vascular remodeling refers to changes in the structure and function of blood vessels under pathological or physiological conditions,typically occurring during processes such as tissue damage repair and disease progression.Investigating the mechanisms of vascular remodeling helps in understanding the progression of CVD,thereby developing more effective early diagnosis and treatment plans,and providing new insights for the prevention and treatment of CVD.The modeling methods of vascular remodeling are the foundation for studying vascular remodeling.Significant progress has been made in vascular remodeling models for studying multiple disease mechanisms,and they are particularly important in the fields of atherosclerosis,hypertension,and vascular remodeling.Common animal models for vascular remodeling include rats,mice,pigs,and other species.Research methods cover mechanical injury,drug intervention,genetic modification,and so on.Different types of animal models have their own advantages.For example,mouse and rat models are suitable for gene studies and high-throughput screening,while rabbit and monkey models,due to their closer resemblance to human pathology,are helpful for simulating vascular remodeling under clinical conditions.Among them,rat models are widely used as frontline models in medical research due to their cost-effectiveness and ease of operation.Current vascular remodeling models mainly rely on classical methods(such as carotid artery balloon injury method,ligation method,and arterial clamping)and are combined with emerging dietary methods(such as high-fat diet,high-salt diet)for construction.Different rat modeling methods are selected according to different experimental needs.The combination of these methods can effectively simulate different mechanisms of vascular remodeling and provide reliable animal models for CVD research.In addition,these rat models can reflect vascular responses under different pathological conditions,offering an important experimental basis for drug development and the formulation of disease treatment strategies.Although these rat models provide valuable tools for vascular remodeling research,challenges such as large model variability,poor reproducibility,and differences from clinical manifestations remain.Future research should focus on improving the accuracy and reliability of existing models to develop new animal models.This article uses rats as examples to summarize the current research progress,model types,and applications of vascular remodeling models,particularly their value in CVD and vascular remodeling research,and provides a theoretical reference for future vascular remodeling-related research by reviewing the advantages and disadvantages of different rat vascular remodeling models.
6.Application Progress and Classification Analysis of Rat Vascular Remodeling Models
Chaoqi GAO ; Zhibo ZHU ; Xiandong SUN
Laboratory Animal and Comparative Medicine 2025;45(5):542-550
Cardiovascular diseases(CVD)are characterized by high morbidity,disability,and mortality rates,making them one of the leading causes of human death worldwide.Vascular remodeling refers to changes in the structure and function of blood vessels under pathological or physiological conditions,typically occurring during processes such as tissue damage repair and disease progression.Investigating the mechanisms of vascular remodeling helps in understanding the progression of CVD,thereby developing more effective early diagnosis and treatment plans,and providing new insights for the prevention and treatment of CVD.The modeling methods of vascular remodeling are the foundation for studying vascular remodeling.Significant progress has been made in vascular remodeling models for studying multiple disease mechanisms,and they are particularly important in the fields of atherosclerosis,hypertension,and vascular remodeling.Common animal models for vascular remodeling include rats,mice,pigs,and other species.Research methods cover mechanical injury,drug intervention,genetic modification,and so on.Different types of animal models have their own advantages.For example,mouse and rat models are suitable for gene studies and high-throughput screening,while rabbit and monkey models,due to their closer resemblance to human pathology,are helpful for simulating vascular remodeling under clinical conditions.Among them,rat models are widely used as frontline models in medical research due to their cost-effectiveness and ease of operation.Current vascular remodeling models mainly rely on classical methods(such as carotid artery balloon injury method,ligation method,and arterial clamping)and are combined with emerging dietary methods(such as high-fat diet,high-salt diet)for construction.Different rat modeling methods are selected according to different experimental needs.The combination of these methods can effectively simulate different mechanisms of vascular remodeling and provide reliable animal models for CVD research.In addition,these rat models can reflect vascular responses under different pathological conditions,offering an important experimental basis for drug development and the formulation of disease treatment strategies.Although these rat models provide valuable tools for vascular remodeling research,challenges such as large model variability,poor reproducibility,and differences from clinical manifestations remain.Future research should focus on improving the accuracy and reliability of existing models to develop new animal models.This article uses rats as examples to summarize the current research progress,model types,and applications of vascular remodeling models,particularly their value in CVD and vascular remodeling research,and provides a theoretical reference for future vascular remodeling-related research by reviewing the advantages and disadvantages of different rat vascular remodeling models.
7.Analysis of effect and safety of vibrating mesh atomization inhalation of PS combined with NCPAP on neonatal respiratory distress syndrome
Zhibo GAO ; Ye LI ; Yushen LIU
Clinical Medicine of China 2025;41(5):321-328
Objective:To analyze the effect and safety of vibrating mesh atomization inhalation of pulmonary surfactant (PS) combined with nasal continuous positive airway pressure (NCPAP) in the treatment of neonatal respiratory distress syndrome (NRDS).Methods:150 Children with NRDS in department of pediatrics of the Second Affiliated Hospital of Air Force Medical University from May 2021 to May 2024 were enrolled as study subjects for a prospective cohort study. According to the propensity score matching, children who adopted traditional intratracheal infusion of PS combined with NCPAP were selected as infusion group (75 cases), and children who received vibrating mesh atomization inhalation of PS combined with NCPAP treatment were included in atomization group (75 cases). The therapeutic effect, breathing conditions, blood gas changes [pH value, arterial partial pressure of oxygen (PaO 2), arterial partial pressure of carbon dioxide (PaCO 2)] and NCPAP parameters changes [fraction of inspired oxygen (FiO 2), oxygenation index (OI), positive end-expiratory pressure (PEEP)] before and after treatment and incidence rates of adverse reactions were compared between groups. Normally distributed quantitative data were expressed as xˉ± s, and t test was used for inter-group comparison. Counting data were expressed as case(%), and χ2 test was used for inter-group comparison. Comparison of repeated measurement indicators at different time points using repeated meausurement analysis of variance. Results:There was no statistical significance in the total effective rate of treatment between groups ( P>0.05). The NCPAP treatment time and oxygen therapy time were (4.69±0.61) d and (14.52±1.16) d in atomization group, significantly shorter than (5.08±0.80) d and (15.30±1.28) d in infusion group ( t=3.36, 3.91, P=0.001, <0.001). The success rate of one-time weaning in atomization group was 88.00% (66/75), significantly higher than 73.33% (55/75) in infusion group ( χ2=5.17, P=0.023). After 3 and 7 days of treatment, the pH [(3 d : 7.31±0.04, 7 d: 7.34±0.03) and (3 d: 7.35±0.03, 7 d: 7.38±0.02)], PaO 2 [(3 d: (58.55±6.51) mmHg (1 mmHg=0.133 kPa), 7 d: (68.19±7.58) mmHg ) and (3 d: (65.16±7.24) mmHg, 7 d: (75.57±8.40) mmHg)] in infusion group and atomization group increased obviously over time, and the pH and PaO 2 were significantly higher in atomization group than those in infusion group ( t=6.93, 8.68, 5.88, 5.65, all P<0.001). The PaCO 2 in infusion group and atomization group (3 d: (48.45±5.38 ) mmHg, 7 d: (43.64±4.85 ) mmHg) and (3 d: (45.41±5.02) mmHg, 7 d: (40.35±4.59) mmHg) decreased obviously over time at 3 and 7 days of treatment, and the PaCO 2 in atomization group was significantly lower than that in infusion group ( t=3.58, 4.27, both P<0.001). After 3 days of treatment, FiO 2 [(41.06±4.67)% and (38.52±4.21)%] and PEEP [(4.39±0.19) cmH 2O (1 cmH 2O=0.098 kPa) and (4.28±0.13) cmH 2O] in infusion group and atomization group decreased obviously, and the indicators in atomization group were significantly lower than those in infusion group ( t=3.50, 4.14, both P<0.001). After 3 days of treatment, oxygenation index (OI) in infusion group and atomization group [(278.35±30.48) mmHg and (296.67±32.96) mmHg] increased obviously, and the OI in atomization group was significantly higher than that in infusion group ( t=3.53, P<0.001). The incidence of adverse reactions in atomization group was 4.00% (3/75), significantly lower than 13.34% (10/75) in infusion group ( χ2=4.13, P=0.042). Conclusion:Both vibrating mesh atomization inhalation of PS or traditional infusion of PS combined with NCPAP have similar efficacy in the treatment of NRDS, but vibrating mesh atomization inhalation of PS combined with NCPAP can more effectively improve the breathing conditions, blood gas indicators and NCPAP parameters of children, and has higher safety.
8.Protective mechanism of Dachengqi decoction on intestinal mucosal barrier:a network pharmacology study focused on autophagy
Xing LU ; Kai ZHANG ; Jing ZHAO ; Shiya ZHANG ; Zhibo LI ; Xinjing GAO ; Lei XU ; Chengfen YIN
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2025;32(4):454-459
Objective To explore and verify the active components of Dachengqi decoction in regulating autophagy and its mechanism of protecting the intestinal mucosal barrier through network pharmacology and animal experiments.Methods The chemical components and autophagy-related target points of Dachengqi decoction were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database Analysis Platform(TCMSP)and GeneCards databases.The intersection of the drug target points and disease target points was taken and analyzed.The Cytoscape 3.10.2 software's Network Analyzer tool was used to analyze the drug components and target points,and the core target points were screened out to construct a traditional Chinese medicine compound regulatory network.The drug active component target point-disease network model and protein-protein interaction(PPI)network were visualized.Then,30 C57BL/6J mice were randomly divided into the Dachengqi decoction group,the intestinal infection group,and the control group,with 10 mice in each group.The intestinal infection group was given 200 μL/d of Klebsiella pneumoniae strain by gavage for 5 consecutive days,with a colony count of 109 CFU/mL,to create an intestinal infection model.The control group was given 200 μL/d of sterile normal saline by gavage.The Dachengqi decoction group(drug composition:Rhubarb 12 g,Aurantii Fructus 12 g,Magnolia Officinalis 24 g,Mirabilite 9 g,the drugs were dissolved in boiling distilled water to make a 1 kg/L solution)was given by gavage at a dose of 8 g·kg-1·d-1 for 3 consecutive days,and then given Klebsiella pneumoniae by gavage for 5 consecutive days on the 4th day.Detection indicators and methods:after the experiment,the mice were sacrificed and the terminal ileum tissues were collected.The tissues were stained with hematoxylin-eosin(HE),and the pathological changes of the intestinal mucosa were observed under a light microscope;immunofluorescence staining was used to observe the positive expressions of junction proteins ZO-1,Claudin-2,light chain 3-Ⅱ(LC3-Ⅱ),and Beclin-1 and the intestinal mucosal autophagy;the mRNA expression levels of autophagy genes were determined by polymerase chain reaction(PCR).Results The intersection of the obtained drug targets and disease targets yielded 111 potential autophagy-related targets for drug treatment of diseases.Key targets included β2-adrenergic receptor(ADRB2),heme oxygenase-1(HO-1),etc.,and the signaling pathways involved included AMP-activated protein kinase(AMPK)pathway,mammalian target of rapamycin(mTOR)pathway,etc.Animal experiments confirmed that the intestinal mucosal barrier function in the Dachengqi decoction group was better than that in the intestinal infection group,and the positive expression of microtubule-associated protein 1 lingt chain 3-Ⅱ(LC3-Ⅱ)and autophagy gene Beclin1 was significantly higher than that in the intestinal infection group.Transcriptome sequencing results showed that the key genes associated with autophagy and oxidative stress included ADRB2,HO-1,etc.The mRNA expression levels of ADRB2 and HO-1 in the Dachengqi decoction group were significantly higher than those in the intestinal infection group[HO-1 mRNA expression(FPKM):11.20±0.80 vs.6.63±0.53,ADRB2 mRNA expression(FPKM):6.98±0.54 vs.3.98±0.32,both P<0.01],verifying some of the predictions from network pharmacology.Conclusions Dachengqi decoction regulates autophagy through multiple components,multiple targets and multiple pathways,protecting the intestinal mucosal barrier function and reducing the translocation of intestinal microbiota.This lays a certain foundation for further in-depth research on the mechanism of reducing intestinal bacterial translocation by Dachengqi decoction.
9.Epidemiological characteristics of human respiratory syncytial virus among acute respiratory infection cases in 16 provinces of China from 2009 to 2023
Aili CUI ; Baicheng XIA ; Zhen ZHU ; Zhibo XIE ; Liwei SUN ; Jin XU ; Jing XU ; Zhong LI ; Linqing ZHAO ; Xiaoru LONG ; Deshan YU ; Bing ZHU ; Feng ZHANG ; Min MU ; Hui XIE ; Liang CAI ; Yun ZHU ; Xiaoling TIAN ; Bing WANG ; Zhenguo GAO ; Xiaoqing LIU ; Binzhi REN ; Guangyue HAN ; Kongxin HU ; Yan ZHANG
Chinese Journal of Preventive Medicine 2024;58(7):945-951
Objective:To understand the epidemiological characteristics of human respiratory syncytial virus (HRSV) among acute respiratory infection (ARI) cases in 16 provinces of China from 2009 to 2023.Methods:The data of this study were collected from the ARI surveillance data from 16 provinces in China from 2009 to 2023, with a total of 28 278 ARI cases included in the study. The clinical specimens from ARI cases were screened for HRSV nucleic acid from 2009 to 2023, and differences in virus detection rates among cases of different age groups, regions, and months were analyzed.Results:A total of 28 278 ARI cases were enrolled from January 2009 to September 2023. The age of the cases ranged from<1 month to 112 years, and the age M ( Q1, Q3) was 3 years (1 year, 9 years). Among them, 3 062 cases were positive for HRSV nucleic acid, with a total detection rate of 10.83%. From 2009 to 2019, the detection rate of HRSV was 9.33%, and the virus was mainly prevalent in winter and spring. During the Corona Virus Disease 2019 (COVID-19) pandemic, the detection rate of HRSV fluctuated between 6.32% and 18.67%. There was no traditional winter epidemic peak of HRSV from the end of 2022 to the beginning of 2023, and an anti-seasonal epidemic of HRSV occurred from April to May 2023. About 87.95% (2 693/3 062) of positive cases were children under 5 years old, and the difference in the detection rate of HRSV among different age groups was statistically significant ( P<0.001), showing a decreasing trend of HRSV detection rate with the increase of age ( P<0.001). Among them, the HRSV detection rate (25.69%) was highest in children under 6 months. Compared with 2009-2019, the ranking of HRSV detection rates in different age groups changed from high to low between 2020 and 2023, with the age M (Q1, Q3) of HRSV positive cases increasing from 1 year (6 months, 3 years) to 2 years (11 months, 3 years). Conclusion:Through 15 years of continuous HRSV surveillance analysis, children under 5 years old, especially infants under 6 months old, are the main high-risk population for HRSV infection. During the COVID-19 pandemic, the prevalence and patterns of HRSV in China have changed.
10.Pathogenetic investigation of an outbreak of upper respiratory tract infection in a kindergarten in Baiyin City, Gansu Province
Shu LIANG ; Hui ZHANG ; Zhibo XIE ; Genxia GAO ; Biao WANG ; Miao WANG ; Huan WEI ; Xiaoshu ZHANG
Chinese Journal of Preventive Medicine 2024;58(10):1593-1597
This study focuses on the cases(mainly characterized by respiratory symptoms such as cough, runny nose, fever, sore throat, and nasal congestion)of an outbreak of upper respiratory tract infections in a kindergarten in Jingyuan County, Baiyin City, Gansu Province, in May 2023. The epidemiological data were collected, and pharyngeal swab specimens were also obtained from the patients. The specimens of the research participants were subjected to respiratory multi-pathogen testing, and the positive specimens were further analyzed by sequencing the second hypervariable region (HRV2) of the G gene of respiratory syncytial virus (RSV) and constructing a phylogenetic tree. A total of 90 patients were collected, with an incidence rate of 22.84% (90/394), and the highest incidence was observed in the junior class group at 29.55%. Among the 17 pharyngeal swab specimens collected, 16 specimens were identified with the A subtype of respiratory syncytial virus. Sequencing analysis confirmed that it was the A subtype ON1 genotype. Based on the aforementioned testing results, it can be concluded that the current epidemic was primarily caused by infection with the A subtype of respiratory syncytial virus. Following the implementation of intervention measures, the epidemic has been effectively controlled.

Result Analysis
Print
Save
E-mail